Anticorps Recombinant de lapin anti-LIFR

LIFR Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

250110B3

N° de cat : 98432-2-RR

Synonymes

CD118, LIF R, LIF receptor, LIF-R, SJS2

---

Galerie de données de validation

• 

  FC experiment of JAR using 98432-2-RR

  1x10^6 JAR cells were surface stained with 0.25 ug Anti-Human LIFR Rabbit RecAb (98432-2-RR, Clone: 250110B3) (red) or Rabbit IgG Isotype Control RecAb (98136-1-RR, Clone: 240953C9) (blue), and PE-Conjugated Goat Anti-Rabbit IgG(H+L). Cells were not fixed.

---

Applications testées

• Résultats positifs en cytométrie: cellules JAR,

Dilution recommandée

Application	Dilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98432-2-RR cible LIFR dans les applications de FC et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: LIFR Protéine recombinante Eg2599
• Nom complet: leukemia inhibitory factor receptor alpha
• Masse moléculaire calculée: 124 kDa
• Numéro d’acquisition GenBank: NM_001127671.1
• Symbole du gène: LIFR
• Identification du gène (NCBI): 3977
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS with 0.09% sodium azide
• Conditions de stockage: Store at 2 - 8°C. Stable for one year after shipment.

Informations générales

LIFR, also known as CD118, is a subunit of a receptor for leukemia inhibitory factor (LIF). LIF is a pleiotropic cytokine of the interleukin-6 family that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIFR is the low-affinity binding chain that, together with the high-affinity converter subunit gp130, forms a high-affinity receptor complex that mediates the action of LIF. The high-affinity complex also binds a related cytokine, oncostatin M (PMID: 8999038). LIFR has also been identified as a breast cancer metastasis suppressor that functions through the HIPPO-YAP pathway (PMID: 23001183).

{{ptg:RelatedPrimaryAntibodies}}